These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30917493)

  • 1. Neuromuscular Plasticity in a Mouse Neurotoxic Model of Spinal Motoneuronal Loss.
    Gulino R; Vicario N; Giunta MAS; Spoto G; Calabrese G; Vecchio M; Gulisano M; Leanza G; Parenti R
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30917493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitigating the Functional Deficit after Neurotoxic Motoneuronal Loss by an Inhibitor of Mitochondrial Fission.
    Ciuro M; Sangiorgio M; Cacciato V; Cantone G; Fichera C; Salvatorelli L; Magro G; Leanza G; Vecchio M; Valle MS; Gulino R
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cell fate determinants and plastic changes after neurotoxic lesion of adult mice spinal cord by cholera toxin-B saporin.
    Gulino R; Perciavalle V; Gulisano M
    Eur J Neurosci; 2010 Apr; 31(8):1423-34. PubMed ID: 20384775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-disease comparison of amyotrophic lateral sclerosis and spinal muscular atrophy reveals conservation of selective vulnerability but differential neuromuscular junction pathology.
    Comley LH; Nijssen J; Frost-Nylen J; Hedlund E
    J Comp Neurol; 2016 May; 524(7):1424-42. PubMed ID: 26502195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic treatment with lithium does not improve neuromuscular phenotype in a mouse model of severe spinal muscular atrophy.
    Dachs E; Piedrafita L; Hereu M; Esquerda JE; Calderó J
    Neuroscience; 2013 Oct; 250():417-33. PubMed ID: 23876328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis.
    Yoo YE; Ko CP
    Exp Neurol; 2011 Sep; 231(1):147-59. PubMed ID: 21712032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
    Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
    Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory function after selective respiratory motor neuron death from intrapleural CTB-saporin injections.
    Nichols NL; Vinit S; Bauernschmidt L; Mitchell GS
    Exp Neurol; 2015 May; 267():18-29. PubMed ID: 25476493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synaptic defects in the spinal and neuromuscular circuitry in a mouse model of spinal muscular atrophy.
    Ling KK; Lin MY; Zingg B; Feng Z; Ko CP
    PLoS One; 2010 Nov; 5(11):e15457. PubMed ID: 21085654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clobetasol promotes neuromuscular plasticity in mice after motoneuronal loss via sonic hedgehog signaling, immunomodulation and metabolic rebalancing.
    Vicario N; Spitale FM; Tibullo D; Giallongo C; Amorini AM; Scandura G; Spoto G; Saab MW; D'Aprile S; Alberghina C; Mangione R; Bernstock JD; Botta C; Gulisano M; Buratti E; Leanza G; Zorec R; Vecchio M; Di Rosa M; Li Volti G; Lazzarino G; Parenti R; Gulino R
    Cell Death Dis; 2021 Jun; 12(7):625. PubMed ID: 34135312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid precursor protein (APP) contributes to pathology in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Bryson JB; Hobbs C; Parsons MJ; Bosch KD; Pandraud A; Walsh FS; Doherty P; Greensmith L
    Hum Mol Genet; 2012 Sep; 21(17):3871-82. PubMed ID: 22678056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TDP-43 as a Modulator of Synaptic Plasticity in a Mouse Model of Spinal Motoneuron Degeneration.
    Gulino R; Forte S; Parenti R; Gulisano M
    CNS Neurol Disord Drug Targets; 2015; 14(1):55-60. PubMed ID: 25613499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Hegedus J; Putman CT; Gordon T
    Neurobiol Dis; 2007 Nov; 28(2):154-64. PubMed ID: 17766128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle atrophy is associated with cervical spinal motoneuron loss in BACHD mouse model for Huntington's disease.
    Valadão PA; de Aragão BC; Andrade JN; Magalhães-Gomes MP; Foureaux G; Joviano-Santos JV; Nogueira JC; Ribeiro FM; Tapia JC; Guatimosim C
    Eur J Neurosci; 2017 Mar; 45(6):785-796. PubMed ID: 27992085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromuscular Junction Dismantling in Amyotrophic Lateral Sclerosis.
    Cappello V; Francolini M
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 28972545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early signs of motoneuron vulnerability in a disease model system: Characterization of transverse slice cultures of spinal cord isolated from embryonic ALS mice.
    Avossa D; Grandolfo M; Mazzarol F; Zatta M; Ballerini L
    Neuroscience; 2006; 138(4):1179-94. PubMed ID: 16442737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defects in neuromuscular junction remodelling in the Smn(2B/-) mouse model of spinal muscular atrophy.
    Murray LM; Beauvais A; Bhanot K; Kothary R
    Neurobiol Dis; 2013 Jan; 49():57-67. PubMed ID: 22960106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase 4 protects from denervation and skeletal muscle atrophy in a murine model of amyotrophic lateral sclerosis.
    Pigna E; Simonazzi E; Sanna K; Bernadzki KM; Proszynski T; Heil C; Palacios D; Adamo S; Moresi V
    EBioMedicine; 2019 Feb; 40():717-732. PubMed ID: 30713114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Clark JA; Southam KA; Blizzard CA; King AE; Dickson TC
    J Chem Neuroanat; 2016 Oct; 76(Pt A):35-47. PubMed ID: 27038603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibition of CTGF/CCN2 activity improves muscle and locomotor function in a murine ALS model.
    Gonzalez D; Rebolledo DL; Correa LM; Court FA; Cerpa W; Lipson KE; van Zundert B; Brandan E
    Hum Mol Genet; 2018 Aug; 27(16):2913-2926. PubMed ID: 29860398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.